Thirdly, the CD38-daratumumab complex is shown to be transferred from MM cells to monocytes and granulocytes in a process known as trogocytosis, even with the absence of phagocytosis of tumor cells [116]. This evidence concerns the gene CD38 and Miyoshi myopathy.